Brandon Capital is a leading Australasian life science venture capital firm that invests in and helps develop early-stage medical research and biotechnology companies. With a focus on translating scie
ntific breakthroughs into life-changing therapies, the firm uses its expertise, capital, and a unique collaboration model called Brandon BioCatalyst to support companies from proof-of-concept to commercialization. They have offices in Australia, New Zealand, the United States, and the United Kingdom and have supported over 50 startup companies.
